Operative management of immune checkpoint colitis following in-transit melanoma: Case report

Immune checkpoint inhibitors are increasingly used as powerful anti-neoplastic therapies in the setting of melanoma. Colitis is a known complication of immune checkpoint inhibitors that if often medically managed. We present a patient with stage IV melanoma with demonstrated in-transit disease under...

Descripción completa

Detalles Bibliográficos
Autores principales: Childers, Betzaira G., Donovan, Eileen, Lo, Winifred M., Janowak, Lauren M., Sussman, Jeffrey, Janowak, Christopher F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157394/
https://www.ncbi.nlm.nih.gov/pubmed/37152059
http://dx.doi.org/10.3389/fonc.2023.1120808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157394/
https://www.ncbi.nlm.nih.gov/pubmed/37152059
http://dx.doi.org/10.3389/fonc.2023.1120808

Ejemplares similares